Thorne Healthtech Inc
NASDAQ:THRN
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
US |
T
|
Thorne Healthtech Inc
NASDAQ:THRN
|
549.4m USD | 3.6 | |
FR |
L'Oreal SA
PAR:OR
|
243.6B EUR | 8.4 | ||
UK |
Unilever PLC
LSE:ULVR
|
107.9B GBP | 6.9 | ||
IN |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 11 | ||
US |
Estee Lauder Companies Inc
NYSE:EL
|
47.9B USD | 8.4 | ||
UK |
HALEON PLC
LSE:HLN
|
30.3B GBP | 1.8 | ||
DE |
Beiersdorf AG
XETRA:BEI
|
33.5B EUR | 4 | ||
JP |
Kao Corp
TSE:4452
|
3.2T JPY | 3.2 | ||
IN |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.4T INR | 9.4 | ||
JP |
Shiseido Co Ltd
TSE:4911
|
1.9T JPY | 3 | ||
IN |
Dabur India Ltd
NSE:DABUR
|
974.9B INR | 10.3 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.